- Home
- KGS vs VCYT Comparison
KGS vs VCYT Comparison
Compare KGS & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KGS | VCYT |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | KGS | VCYT |
|---|---|---|
| Price | $36.99 | $43.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $43.00 | ★ $45.38 |
| AVG Volume (30 Days) | ★ 1.8M | 1.0M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | ★ 5.26% | N/A |
| EPS Growth | ★ 224.29 | N/A |
| EPS | ★ 0.84 | 0.38 |
| Revenue | ★ $1,284,748,000.00 | $495,141,000.00 |
| Revenue This Year | $13.95 | $16.02 |
| Revenue Next Year | $7.27 | $10.74 |
| P/E Ratio | ★ $44.25 | $112.61 |
| Revenue Growth | ★ 19.43 | 16.41 |
| 52 Week Low | $29.25 | $22.61 |
| 52 Week High | $50.43 | $50.71 |
Technical Indicators
Market Signals| Indicator | KGS | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 50.49 |
| Support Level | $35.73 | $41.55 |
| Resistance Level | $38.27 | $45.17 |
| Average True Range (ATR) | 1.00 | 1.77 |
| MACD | 0.26 | -0.70 |
| Stochastic Oscillator | 71.22 | 16.54 |
Price Performance
Historical ComparisonAbout KGS Kodiak Gas Services Inc.
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.